American Journal of Preventive Medicine
Volume 38, Issue 3 , Pages 296-302 , March 2010

Ultraviolet B Irradiance and Incidence Rates of Bladder Cancer in 174 Countries

  • Sharif B. Mohr, MPH

      Affiliations

    • Department of Family and Preventive Medicine, University of California, San Diego, California
    • Department of Health Sciences and Epidemiology, Naval Health Research Center, San Diego, California
  • ,
  • Cedric F. Garland, DrPH

      Affiliations

    • Department of Family and Preventive Medicine, University of California, San Diego, California
    • Department of Health Sciences and Epidemiology, Naval Health Research Center, San Diego, California
    • Corresponding Author InformationAddress correspondence and reprint requests to: Cedric F. Garland, DrPH, Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla CA 92093-0631
  • ,
  • Edward D. Gorham, PhD

      Affiliations

    • Department of Family and Preventive Medicine, University of California, San Diego, California
    • Department of Health Sciences and Epidemiology, Naval Health Research Center, San Diego, California
  • ,
  • William B. Grant, PhD

      Affiliations

    • Sunlight, Nutrition and Health Research Center, San Francisco, California
  • ,
  • Frank C. Garland, PhD

      Affiliations

    • Department of Family and Preventive Medicine, University of California, San Diego, California
    • Department of Health Sciences and Epidemiology, Naval Health Research Center, San Diego, California

References 

  1. Pashos CL, Botteman MF, Laskin BL, Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 2002;10(6):311–322
  2. Brennan P, Bogillot O, Cordier S, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer. 2000;86(2):289–294
  3. Olfert SM, Felknor SA, Delclos GL. An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures. South Med J. 2006;99(11):1256–1263
  4. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. version 2.0. www-dep.iarc.fr/.
  5. American Cancer Society. Cancer facts and figures, 2008. Atlanta GA: American Cancer Society; 2008;
  6. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002;94(6):1867–1875
  7. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–377
  8. Garland C, Garland F, Gorham E, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252–261
  9. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case–control study. Carcinogenesis. 2008;29(1):93–99
  10. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991–1997
  11. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103(3–5):708–711
  12. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164–1169
  13. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502–1508
  14. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2(8673):1176–1178
  15. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32(3):210–216
  16. Tangrea J, Helzlsouer K, Pietinen P, et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997;8(4):615–625
  17. Tworoger SS, Lee IM, Buring JE, Rosner B, Hollis BW, Hankinson SE. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(4):783–788
  18. Adams JS, Clemens TL, Parrish JA, Holick MF. Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med. 1982;306(12):722–725
  19. Engelsen O, Brustad M, Aksnes L, Lund E. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol. 2005;81(6):1287–1290
  20. Punnonen R, Gillespy M, Hahl M. Serum 25-OHD, vitamin A and vitamin E concentrations in healthy Finnish and Floridian women. Int J Vit Nutr Res. 1988;58:37–39
  21. Holick M. Photosynthesis of previtamin D3 in human skin and the physiological consequences. Science. 1980;210:203–205
  22. Meyer HE, Holvik K, Lofthus CM, Tennakoon SU. Vitamin D status in Sri Lankans living in Sri Lanka and Norway. Br J Nutr. 2008;99(5):941–944
  23. Hagenau T, Vest R, Gissel TN, et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int. 2009;20(1):133–140
  24. Pelucchi C, La Vecchia C. Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. Eur J Cancer Prev. 2009;18(1):62–68
  25. Reulen RC, Kellen E, Buntinx F, Brinkman M, Zeegers MP. A meta-analysis on the association between bladder cancer and occupation. Scand J Urol Nephrol Suppl. 2008;(218):64–78
  26. National Aeronautics and Space Administration. Solar Radiation and the Earth System. http://edmall.gsfc.nasa.gov/inv99Project.Site/Pages/science-briefs/ed-stickler/ed-irradiance
  27. National Aeronautics and Space Administration. International Satellite Cloud Climatology Project database. isccp.giss.nasa.gov/products/browsed2.html
  28. Columbia University. Center for International Earth Science Information Network. sedac.ciesin.columbia.edu/ozone/rtm/mval.html
  29. Mackay J, Eriksen M. The tobacco atlas. Geneva: WHO; 2002;
  30. Armenian HK. Incubation periods of cancer: old and new. J Chronic Dis. 1987;(40S 2):9S–15S
  31. WHO. World Health Report 2004 Statistical Annex. www.who.int/whr/2004/annex/en/index.html
  32. Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res. 1999;14(2):215–220
  33. Matsunawa M, Amano Y, Endo K, et al. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci. 2009;109(1):50–58
  34. Sachs J, Andrew D, Gallup J. The geography of poverty and wealth. Sci Am. 2001;71–74March
  35. El-Khoby T, Galal N, Fenwick A, et al. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg. 2000;62(2S):88–99
  36. Gouda I, Mokhtar N, Bilal D, El-Bolkainy T, El-Bolkainy NM. Bilharziasis and bladder cancer: a time trend analysis of 9843 patients. J Egypt Natl Canc Inst. 2007;19(2):158–162
  37. Youssef RM, Abou-Khatwa SA, Fouad HM. Prevalence of smoking and age of initiation in Alexandria, Egypt. East Mediterr Health J. 2002;8(4–5):626–637
  38. Traquinho GA, Quinto L, Nala RM, Gama Vaz R, Corachan M. Schistosomiasis in northern Mozambique. Trans R Soc Trop Med Hyg. 1998;92(3):279–281
  39. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol. 2006;22(7):332–339
  40. Madronich S, McKenzie RL, Bjorn LO, Caldwell MM. Changes in biologically active ultraviolet radiation reaching the Earth's surface. J Photochem Photobiol B. 1998;46(1–3):5–19
  41. De Stefani E, Boffetta P, Deneo-Pellegrini H, et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer. 2007;7:57
  42. Graham H. Smoking prevalence among women in the European community 1950–1990. Soc Sci Med. 1996;43(2):243–254
  43. Kiemeney LA, Straatman H, Witjes JA. Decreasing bladder cancer mortality in the Netherlands. Br J Urol. 1996;78(5):686–690
  44. Mohr S, Garland C, Gorham E, Grant W, Garland F. Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J. 2008;14(3):255–260
  45. Garland CF, Mohr SB, Gorham ED, Grant WB, Garland FC. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am J Prev Med. 2006;31(6):512–514
  46. Mohr S, Garland C, Gorham E, Grant W, Highfill R, Garland F. Mapping vitamin D deficiency, breast cancer, and colorectal cancer. In: Proceedings of the ESRI International User Conference. Redlands CA: ESRI; 2005;p. 1468
  47. Garland C, Comstock G, Garland F, Helsing K, Shaw E, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2:1176–1178
  48. Rothman KS. Modern epidemiology. 2nd ed.. Philadelphia PA: Lippincott-Raven; 1998;
  49. Brenner H, Greenland S, Savitz DA. The effects of nondifferential confounder misclassification in ecologic studies. Epidemiology. 1992;3(5):456–459
  50. Brenner H, Savitz DA, Jockel KH, Greenland S. Effects of nondifferential exposure misclassification in ecologic studies. Am J Epidemiol. 1992;135(1):85–95
  51. Bjork J, Stromberg U. Effects of systematic exposure assessment errors in partially ecologic case–control studies. Int J Epidemiol. 2002;31(1):154–160
  52. Webster T. Commentary: does the spectre of ecologic bias haunt epidemiology?. Int J Epidemiol. 2002;31(1):161–162
  53. Dean HT, Arnold FA, Jay P, Knutson JW. Studies on mass control of dental caries through fluoridation of the public water supply. Public Health Rep. 1950;65(43):1403–1408

PII: S0749-3797(09)00926-X

doi: 10.1016/j.amepre.2009.10.044

American Journal of Preventive Medicine
Volume 38, Issue 3 , Pages 296-302 , March 2010